Mixing Russia's Sputnik V, AstraZeneca shots proves safe in small trial -RDIF

MOSCOW - Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct Investment Fund (RDIF) said on Friday.

The trial involved 50 people and began in Azerbaijan in February, RDIF, which is responsible for marketing Sputnik V vaccine abroad, said in the statement. Full results of the trial, including data on the immune response produced by the combination vaccine, would be published next month, RDIF said.